Does INFLIXIMAB-DYYB Cause Off label use? 14,256 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 14,256 reports of Off label use have been filed in association with INFLIXIMAB-DYYB (ZYMFENTRA). This represents 55.7% of all adverse event reports for INFLIXIMAB-DYYB.
14,256
Reports of Off label use with INFLIXIMAB-DYYB
55.7%
of all INFLIXIMAB-DYYB reports
274
Deaths
3,718
Hospitalizations
How Dangerous Is Off label use From INFLIXIMAB-DYYB?
Of the 14,256 reports, 274 (1.9%) resulted in death, 3,718 (26.1%) required hospitalization, and 71 (0.5%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for INFLIXIMAB-DYYB. However, 14,256 reports have been filed with the FAERS database.
What Other Side Effects Does INFLIXIMAB-DYYB Cause?
Condition aggravated (10,275)
Intentional product use issue (7,549)
Inappropriate schedule of product administration (5,977)
Arthralgia (4,615)
Drug ineffective (3,112)
Fatigue (3,111)
Weight increased (2,848)
Malaise (2,766)
Weight decreased (2,703)
Blood pressure increased (2,309)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which INFLIXIMAB-DYYB Alternatives Have Lower Off label use Risk?
INFLIXIMAB-DYYB vs INFLIXIMAB-QBTX
INFLIXIMAB-DYYB vs INFLIXIMAB, RECOMBINANT
INFLIXIMAB-DYYB vs INFLUENZA A VIRUS A/CALIFORNIA/7/2009 LIVE ANTIGEN\INFLUENZA A VIRUS A/TEXAS/50/2012 LIVE ANTIGEN\INFLUENZA B VIRUS B/BRISBANE/60/2008 LIVE ANTIGEN\INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 LIVE ANTIGEN
INFLIXIMAB-DYYB vs INFLUENZA VIRUS VACCINE
INFLIXIMAB-DYYB vs INFLUENZA VIRUS VACCINE QUADRIVALENT TYPE A+B